Imaging of GABA A receptor gating reveals rapid transitions and lipid interactions, suggesting new insights into neurotransmission.
Type-A γ-aminobutyric receptors (GABA A Rs) are fast pentameric ligand gated ion channels (pLGICs). Within a millisecond, saturating agonist concentrations trigger activity bursts consisting of high-frequency fluctuations between conductive and non-conductive states. These can last for tens to hundreds of milliseconds until, stochastically, receptors adopt stable, long-lived, desensitised conformations. This highly dynamic process, known as gating, controls transient passages of chloride ions across plasma membranes to enable neurotransmission and other fundamental processes in animal physiology. The conformational transitions inside activity bursts, inferred from electrophysiology, have remained inaccessible to structural biology investigation. Here we describe the gating motions of three GABA A receptor variants imaged within the first 10 milliseconds of agonist application by cryogenic electron microscopy (cryo-EM). We illustrate how activation and desensitisation proceed through multiple asymmetric states, supported by major secondary, tertiary and quaternary structural rearrangements, and demonstrate that the same gating principles apply to both homomeric and heteromeric GABA A Rs. Furthermore, we show that cholesterol and phospholipids stabilise newly formed inter-subunit interfaces and obstruct channel pores in short-lived desensitised states, while phosphatidylinositol 4,5-bisphosphate (PIP2) precludes the opening of both α1β3 and α1β3γ2 GABA A R channels. Our results provide a novel framework to interpret decades of electrophysiology observations and suggest a broadly applicable approach to investigate mechanistically the vast arrays of physiological and pharmacological modulators of GABA A Rs and other fast neurotransmitter receptors. Moreover, the subunit interfaces and lipid-binding pockets that form and disappear during GABA A R gating provide new opportunities to discover modulators with improved specificity and therapeutic properties.
No takes yet. Share an insight, caveat, or question.
Mihaylov et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: